Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Rural Physician Workforce Production Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; H.R.1153, Rural Physician Workforce Production Act of 2025.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HOLOGIC, INC. via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Source: Senate LDA
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL |
| 1 |
| 2024 |
| TRAUMA CENTER ASSOCIATION OF AMERICA | 1 | 2024 |
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Puerto Rico Insurance Excise Tax Exemption Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Puerto Rico Insurance Excise Tax Exemption Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Medicaid Dental Benefit Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Medicaid Dental Benefit Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Give Kids a Chance Act of 2024
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
PREVENT HPV Cancers Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
PREVENT HPV Cancers Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Action for Dental Health Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Action for Dental Health Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Oral Health Literacy and Awareness Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Oral Health Literacy and Awareness Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
Dental Loan Repayment Assistance Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Dental Loan Repayment Assistance Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Rural Physician Workforce Production Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: ALSTON & BIRD LLP
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Give Kids a Chance Act of 2023
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
Oral Health Literacy and Awareness Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Oral Health Literacy and Awareness Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Medicaid Dental Benefit Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Medicaid Dental Benefit Act of 2023
Client: ACADEMY OF GENERAL DENTISTRY · Firm: ALSTON & BIRD LLP
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
Cosmetic Supply Chain Transparency Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
Cosmetic Supply Chain Transparency Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Cosmetic Supply Chain Transparency Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Cosmetic Supply Chain Transparency Act of 2021
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Arlington Cemetery Marker Fairness Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Arlington Cemetery Marker Fairness Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · first_quarter · Q1
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2025 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2025 · first_quarter · Q1
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2025 · first_quarter · Q1
General health care issues and Medicare graduate medical education; H.R.1153, Rural Physician Workforce Production Act of 2025.
General health care issues and Medicare reimbursement; issues concerning rural emergency hospitals.
Filing targets: HOUSE OF REPRESENTATIVES
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Issues relating to dental insurance and coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2024 · fourth_quarter · RR
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Policies regarding copay accumulators and impact on rare disease patients.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2024 · third_quarter · Q3
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Issues relating to dental insurance and coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Legislation to improve education and care pathways for patients with rare kidney disease.
TIVITY HEALTH, INC. via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Older Americans Act and Medicare and healthcare issues.
Older Americans Act and Medicare and healthcare issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Issues relating to dental insurance and coverage.
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2024 · second_quarter · Q2
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation regarding the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
TRAUMA CENTER ASSOCIATION OF AMERICA via ALSTON & BIRD LLP
2024 · first_quarter · Q1
General health care issues and Medicare policies/reimbursement issues that impact trauma centers.
General health care issues and Medicare policies/reimbursement issues that impact trauma centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TIVITY HEALTH, INC. via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Older Americans Act and Medicare and healthcare issues.
Older Americans Act and Medicare and healthcare issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2024 · first_quarter · Q1
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Issues relating to dental insurance and coverage.
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Legislation regarding the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023; H.R.2474, Strengthening Medicare for Patients and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Funding for General Dentistry Residency Programs and Oral Health Literacy. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health.
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2023 · third_quarter · Q3
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway.
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2023 · second_quarter · Q2
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023.
General health care issues and Medicare graduate medical education; S.230/H.R.834, Rural Physician Workforce Production Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF GENERAL DENTISTRY via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2023 · first_quarter · Q1
General health care issues and Medicare graduate medical education.
General health care issues and Medicare graduate medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Medicare, Medicaid and general health care issues; S. 1893/H.R. 8508, Rural Physician Workforce Production Act.
Medicare, Medicaid and general health care issues; S. 1893/H.R. 8508, Rural Physician Workforce Production Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation regarding the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease. Policies regarding copay accumulators and impact on rare disease patients.
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Funding for General Dentistry Residency Programs and Oral Health Literacy. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health.
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for General Dentistry Residency Programs and Oral Health Literacy. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health.
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Funding for General Dentistry Residency Programs and Oral Health Literacy. Oral Health Literacy and Awareness Act (S.403/H.R.994). Action for Dental Health Act (H.R.3843). Legislation related to the opioid epidemic. Reauthorization of the Support Act and related changes to the MATE Act. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health. The Promoting Resources to Expand Vaccination, Education and New Treatments for (PREVENT) HPV Cancers Act of 2023 (H.R.3633).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022. Legislation regarding the Orphan Drug Exemption with the Inflation Reduction Act of 2022. H.R.2630/S.652, the SAFE Step Act; H.R.830/S.1375, the HELP Copays Act. Legislation to improve education and care pathways for patients with rare kidney disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for General Dentistry Residency Programs and Oral Health Literacy. Appropriations including Funding for the Centers for Disease Control and Prevention's Office on Smoking and Health.
Issues relating to dental insurance and coverage.
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Dental Loan Repayment Assistance Act (S.2172).
Issues relating to dental insurance and coverage.
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease.
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening.
Legislation regarding the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Legislation related to student debt policy. Resident Education Deferred Interest Act or REDI Act (S.704/H.R.1202). Issues relating to dental insurance and coverage. Legislation related to the opioid epidemic. Issues and advocacy related to the COVID-19 Emergency Temporary Standard rulemaking for the healthcare sector. Legislation and regulations addressing the COVID-19 pandemic. Appropriations including Funding for the Centers for Disease Control and Preventions Office on Smoking and Health. Funding for General Dentistry Residency Programs and Oral Health Literacy at HRSA. Oral Health Literacy and Awareness Act (S.403/H.R.994). Regulations related to the Medicare Physician Fee Schedule Rule and legislation impacting dental coverage and reimbursement under the Medicaid and Medicare programs. Medicaid Dental Benefit Act (S.570/H.R.1342). Strengthening Medicaid Incentives for Licensees Enrolled in Dental Act or SMILED Act (H.R.1422).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Health Resources & Services Administration (HRSA), Substance Abuse & Mental Health Services Administration (SAMHSA)